Abdominal pain in Irritable Bowel Syndrome: A review of putative psychological, neural and neuro-immune mechanisms

Brain, Behavior, and Immunity

Volumn 25, Issue 3, 2011, Pages 386-394

  Elsenbruch, Sigrid ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Anxiety; Imaging; Immune system; Irritable Bowel Syndrome; Pain; Sickness behaviour; Stress; Visceral hyperalgesia

Indexed keywords

BETA DEFENSIN 2; TUMOR NECROSIS FACTOR ALPHA; VANILLOID RECEPTOR 1;

ABDOMINAL PAIN; ANXIETY; CORPUS STRIATUM; CYTOKINE PRODUCTION; DEPRESSION; DISEASE ASSOCIATION; EFFERENT NERVE; ENTEROCHROMAFFIN CELL; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; HYPERALGESIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNE SYSTEM; IRRITABLE COLON; LYMPHOCYTIC INFILTRATION; MENTAL STRESS; NERVE DEGENERATION; NEUROIMAGING; NOCICEPTION; PAIN ASSESSMENT; PAIN THRESHOLD; PATHOPHYSIOLOGY; PERIAQUEDUCTAL GRAY MATTER; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; STRESS; T LYMPHOCYTE ACTIVATION; THALAMUS; VISCERAL PAIN;

ABDOMINAL PAIN; HUMANS; HYPERALGESIA; IRRITABLE BOWEL SYNDROME; PAIN THRESHOLD;

EID: 79551686306     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2010.11.010     Document Type: Review

References (63)

1. Akbar A., Yiangou Y., Facer P., Brydon W.G., Walters J.R., Anand P., Ghosh S. Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain. Gut 2010, 59:767-774.
2. Akbar A., Yiangou Y., Facer P., Walters J.R., Anand P., Ghosh S. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut 2008, 57:923-929.
3. Al-Khatib K., Lin H.C. Immune activation and gut microbes in irritable bowel syndrome. Gut Liver 2009, 3:14-19.
4. Barbara G., Stanghellini V., De Giorgio R., Cremon C., Cottrell G.S., Santini D., Pasquinelli G., Morselli-Labate A.M., Grady E.F., Bunnett N.W., Collins S.M., Corinaldesi R. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004, 126:693-702.
5. Barreau F., Ferrier L., Fioramonti J., Bueno L. New insights in the etiology and pathophysiology of irritable bowel syndrome: contribution of neonatal stress models. Pediatr. Res. 2007, 62:240-245.
6. Berman S.M., Naliboff B.D., Suyenobu B., Labus J.S., Stains J., Ohning G., Kilpatrick L., Bueller J.A., Ruby K., Jarcho J., Mayer E.A. Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome. J. Neurosci. 2008, 28:349-359.
7. Chang L., Sundaresh S., Elliott J., Anton P.A., Baldi P., Licudine A., Mayer M., Vuong T., Hirano M., Naliboff B.D., Ameen V.Z., Mayer E.A. Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis in irritable bowel syndrome. Neurogastroenterol. Motil. 2009, 21:149-159.
8. Coen S.J., Yagüez L., Aziz Q., Mitterschiffthaler M.T., Brammer M., Williams S.C., Gregory L.J. Negative mood affects brain processing of visceral sensation. Gastroenterology 2009, 137:253-261. 261.e1-2.
9. Collins S.M., Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 2009, 136:2003-2014.
10. Cremon C., Gargano L., Morselli-Labate A.M., Santini D., Cogliandro R.F., De Giorgio R., Stanghellini V., Corinaldesi R., Barbara G. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am. J. Gastroenterol. 2009, 104:392-400.
11. Dinan T.G., Clarke G., Quigley E.M., Scott L.V., Shanahan F., Cryan J., Cooney J., Keeling P.W. Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. Am. J. Gastroenterol. 2008, 103:2570-2576.
12. Dinan T.G., Quigley E.M., Ahmed S.M., Scully P., O'Brien S., O'Mahony L., O'Mahony S., Shanahan F., Keeling P.W. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?. Gastroenterology 2006, 130:304-311.
13. Dorn S.D., Palsson O.S., Thiwan S.I., Kanazawa M., Clark W.C., van Tilburg M.A., Drossman D.A., Scarlett Y., Levy R.L., Ringel Y., Crowell M.D., Olden K.W., Whitehead W.E. Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity. Gut 2007, 56:1202-1209.
14. Elsenbruch S., Haag S., Lucas A., Riemenschneider N., Pietsch A., Gerken G., Heijnen C.J., Schedlowski M., Holtmann G. Neuroendocrine and blood pressure responses to rectal distensions in individuals with high and low visceral pain sensitivity. Psychoneuroendocrinology 2007, 32:580-585.
15. Elsenbruch S., Lovallo W.R., Orr W.C. Psychological and physiological responses to postprandial mental stress in women with the irritable bowel syndrome. Psychosom. Med. 2001, 63:805-813.
16. Elsenbruch S., Lucas A., Holtmann G., Haag S., Gerken G., Riemenschneider N., Langhorst J., Kavelaars A., Heijnen C.J., Schedlowski M. Public speaking stress-induced neuroendocrine responses and circulating immune cell redistribution in irritable bowel syndrome. Am. J. Gastroenterol. 2006, 101:2300-2307.
17. Elsenbruch S., Orr W.C. Diarrhea- and constipation-predominant IBS patients differ in postprandial autonomic and cortisol responses. Am. J. Gastroenterol. 2001, 96:460-466.
18. Elsenbruch S., Rosenberger C., Bingel U., Forsting M., Schedlowski M., Gizewski E.R. Patients with irritable bowel syndrome have altered emotional modulation of neural responses to visceral stimuli. Gastroenterology 2010, 139:1310-1319.
19. Elsenbruch S., Rosenberger C., Enck P., Forsting M., Schedlowski M., Gizewski E.R. Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study. Gut 2010, 59:489-495.
20. Forsythe P., Sudo N., Dinan T., Taylor V.H., Bienenstock J. Mood and gut feelings. Brain Behav. Immun. 2010, 24:9-16.
21. Giesecke T., Gracely R.H., Williams D.A., Geisser M.E., Petzke F.W., Clauw D.J. The relationship between depression, clinical pain, and experimental pain in a chronic pain cohort. Arthritis Rheum. 2005, 52:1577-1584.
22. Guthrie E., Barlow J., Fernandes L., Ratcliffe J., Read N., Thompson D.G., Tomenson B., Creed F. Changes in tolerance to rectal distension correlate with changes in psychological state in patients with severe irritable bowel syndrome. Psychosom. Med. 2004, 66:578-582. North of England IBS Research Group.
23. Johnson A.C., Myers B., Lazovic J., Towner R., Greenwood-van Meerveld B. Brain activation in response to visceral stimulation in rats with amygdala implants of corticosterone: an FMRI study. PLoS One 2010, 5:e8573.
24. Kaptchuk T.J., Kelley J.M., Conboy L.A., Davis R.B., Kerr C.E., Jacobson E.E., Kirsch I., Schyner R.N., Nam B.H., Nguyen L.T., Park M., Rivers A.L., McManus C., Kokkotou E., Drossman D.A., Goldman P., Lembo A.J. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome. BMJ 2008, 336:999-1003.
25. Kiank C., Taché Y., Larauche M. Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors. Brain Behav. Immun. 2010, 24:41-48.
26. Kindt S., van Oudenhove L., Broekaert D., Kasran A., Ceuppens J.L., Bossuyt X., Fischler B., Tack J. Immune dysfunction in patients with functional gastrointestinal disorders. Neurogastroenterol. Motil. 2009, 21:389-398.
27. Klinger R., Matter N., Kothe R., Dahme B., Hofmann U.G., Krug F. Unconditioned and conditioned muscular responses in patients with chronic back pain and chronic tension-type headaches and in healthy controls. Pain 2010, 150:66-74.
28. Lembo T., Naliboff B., Munakata J., Fullerton S., Saba L., Tung S., Schmulson M., Mayer E.A. Symptoms and visceral perception in patients with pain-predominant irritable bowel syndrome. Am. J. Gastroenterol. 1999, 94:1320-1326.
29. Lieberman M.D., Jarcho J.M., Berman S., Naliboff B.D., Suyenobu B.Y., Mandelkern M., Mayer E.A. The neural correlates of placebo effects: a disruption account. Neuroimage 2004, 22:447-455.
30. Liebregts T., Adam B., Bredack C., Röth A., Heinzel S., Lester S., Downie-Doyle S., Smith E., Drew P., Talley N.J., Holtmann G. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007, 132:913-920.
31. Lorenz J., Minoshima S., Casey K.L. Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation. Brain 2003, 126:1079-1091.
32. Lu H.C., Hsieh J.C., Lu C.L., Niddam D.M., Wu Y.T., Yeh T.C., Cheng C.M., Chang F.Y., Lee S.D. Neuronal correlates in the modulation of placebo analgesia in experimentally-induced esophageal pain: a 3T-fMRI study. Pain 2010, 148:75-83.
33. Lucas A., Cobelens P.M., Kavelaars A., Heijnen C.J., Holtmann G., Haag S., Gerken G., Langhorst J., Dobos G.J., Schedlowski M., Elsenbruch S. Disturbed in vitro adrenergic modulation of cytokine production in inflammatory bowel diseases in remission. J. Neuroimmunol. 2007, 182:195-203.
34. Lucas A., Holtmann G., Gerken G., Pietsch A., Braun-Lang U., Gilani K., Strassburger K., Gesing S., Janssen O.E., Kavelaars A., Heijnen C.J., Schedlowski M., Elsenbruch S. Visceral pain and public speaking stress: neuroendocrine and immune cell responses in healthy subjects. Brain Behav. Immun. 2006, 20:49-56.
35. Mertz H., Naliboff B., Munakata J., Niazi N., Mayer E.A. Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995, 109:40-52.
36. Moayyedi P., Ford A.C., Talley N.J., Cremonini F., Foxx-Orenstein A.E., Brandt L.J., Quigley E.M. The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010, 59:325-332.
37. Morgan V., Pickens D., Gautam S., Kessler R., Mertz H. Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut 2005, 54:601-607.
38. Murray C.D., Flynn J., Ratcliffe L., Jacyna M.R., Kamm M.A., Emmanuel A.V. Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome. Gastroenterology 2004, 127:1695-1703.
39. Naliboff B.D., Berman S., Suyenobu B., Labus J.S., Chang L., Stains J., Mandelkern M.A., Mayer E.A. Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients. Gastroenterology 2006, 131:352-365.
40. Nees F., Rüddel H., Mussgay L., Kuehl L.K., Römer S., Schächinger H. Alteration of delay and trace eyeblink conditioning in fibromyalgia patients. Psychosom. Med. 2010, 72:412-418.
41. Nozu T., Kudaira M., Kitamori S., Uehara A. Repetitive rectal painful distention induces rectal hypersensitivity in patients with irritable bowel syndrome. J. Gastroenterol. 2006, 41:217-222.
42. O'Mahony S.M., Marchesi J.R., Scully P., Codling C., Ceolho A.M., Quigley E.M., Cryan J.F., Dinan T.G. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol. Psychiatry 2009, 65:263-267.
43. Posserud I., Syrous A., Liotti M., Tack J., Abrahamsson H., Simrén M. Altered rectal perception in irritable bowel syndrome is associated with symptom severity. Gastroenterology 2007, 133:1113-1123.
44. Price D.D., Craggs J., Verne G.N., Perlstein W.M., Robinson M.E. Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain 2007, 127:63-72.
45. Price D.D., Craggs J.G., Zhou Q., Verne G.N., Perlstein W.M., Robinson M.E. Widespread hyperalgesia in irritable bowel syndrome is dynamically maintained by tonic visceral impulse input and placebo/nocebo factors: evidence from human psychophysics, animal models, and neuroimaging. Neuroimage 2009, 47:995-1001.
46. Ringel Y., Drossman D.A., Leserman J.L., Suyenobu B.Y., Wilber K., Lin W., Whitehead W.E., Naliboff B.D., Berman S., Mayer E.A. Effect of abuse history on pain reports and brain responses to aversive visceral stimulation: an FMRI study. Gastroenterology 2008, 134:396-404.
47. Rosas-Ballina M., Tracey K.J. The neurology of the immune system: neural reflexes regulate immunity. Neuron 2009, 64:28-32.
48. Rosenberger C., Elsenbruch S., Scholle A., de Greiff A., Schedlowski M., Forsting M., Gizewski E.R. Effects of psychological stress on the cerebral processing of visceral stimuli in healthy women. Neurogastroenterol. Motil. 2009, 21:740-745.
49. Santos J., Saperas E., Nogueiras C., Mourelle M., Antolín M., Cadahia A., Malagelada J.R. Release of mast cell mediators into the jejunum by cold pain stress in humans. Gastroenterology 1998, 114:640-648.
50. Schneider C., Palomba D., Flor H. Pavlovian conditioning of muscular responses in chronic pain patients: central and peripheral correlates. Pain 2004, 112:239-247.
51. Schweinhardt P., Kalk N., Wartolowska K., Chessell I., Wordsworth P., Tracey I. Investigation into the neural correlates of emotional augmentation of clinical pain. Neuroimage 2008, 40:759-766.
52. Scully P., McKernan D.P., Keohane J., Groeger D., Shanahan F., Dinan T.G., Quigley E.M. Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am. J. Gastroenterol. 2010, 105:2235-2243.
53. Seminowicz D.A., Labus J.S., Bueller J.A., Tillisch K., Naliboff B.D., Bushnell M.C., Mayer E.A. Regional gray matter density changes in brains of patients with irritable bowel syndrome. Gastroenterology 2010, 139:48-57.
54. Spiller R., Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009, 136:1979-1988.
55. Thompson J.J., Elsenbruch S., Harnish M.J., Orr W.C. Autonomic functioning during REM sleep differentiates IBS symptom subgroups. Am. J. Gastroenterol. 2002, 97:3147-3153.
56. Tyler K., Moriceau S., Sullivan R.M., Greenwood-van Meerveld B. Long-term colonic hypersensitivity in adult rats induced by neonatal unpredictable vs. predictable shock. Neurogastroenterol. Motil. 2007, 19:761-768.
57. Van Damme S., Crombez G., Eccleston C., Koster E.H. Hypervigilance to learned pain signals: a componential analysis. J. Pain 2006, 7:346-357.
58. Videlock E.J., Adeyemo M., Licudine A., Hirano M., Ohning G., Mayer M., Mayer E.A., Chang L. Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome. Gastroenterology 2009, 137:1954-1962.
59. Vogt B.A. Pain and emotion interactions in subregions of the cingulate gyrus. Nat. Rev. Neurosci. 2005, 6:533-544.
60. Wiech K., Ploner M., Tracey I. Neurocognitive aspects of pain perception. Trends Cogn. Sci. 2008, 12:306-313.
61. Wiech K., Tracey I. The influence of negative emotions on pain: behavioral effects and neural mechanisms. Neuroimage 2009, 47:987-994.
62. Wieseler-Frank J., Maier S.F., Watkins L.R. Immune-to-brain communication dynamically modulates pain: physiological and pathological consequences. Brain Behav. Immun. 2005, 19:104-111.
63. Williams A.E., Rhudy J.L. The influence of conditioned fear on human pain thresholds: does preparedness play a role?. J. Pain 2007, 8:598-606.